WOIPPY, MOSELLE, FRANCE, June 1, 2026 — ABL Diagnostics (FR001400AHX6 – “ABLD”), an innovative company specialized in microbiology and pathogen sequencing, today announced the continued expansion of its UltraGene product line, reinforcing the company’s development of flexible multiplex qPCR…